Applications of the CRISPR–Cas9 system in cancer biology
Author(s)
Sanchez-Rivera, Francisco Javier; Jacks, Tyler E.
Downloadnihms712031.pdf (2.532Mb)
OPEN_ACCESS_POLICY
Open Access Policy
Creative Commons Attribution-Noncommercial-Share Alike
Terms of use
Metadata
Show full item recordAbstract
The prokaryotic type II CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-CRISPR-associated 9) system is rapidly revolutionizing the field of genetic engineering, allowing researchers to alter the genomes of a large range of organisms with relative ease. Experimental approaches based on this versatile technology have the potential to transform the field of cancer genetics. Here, we review current approaches for functional studies of cancer genes that are based on CRISPR-Cas, with emphasis on their applicability for the development of next-generation models of human cancer.
Date issued
2015-06Department
Massachusetts Institute of Technology. Department of Biology; Koch Institute for Integrative Cancer Research at MITJournal
Nature Reviews Cancer
Publisher
Nature Publishing Group
Citation
Sánchez-Rivera et al. “Applications of the CRISPR–Cas9 System in Cancer Biology.” Nature Reviews Cancer 15, 7 (June 2015): 387–393 © 2015 Macmillan Publishers Limited
Version: Author's final manuscript
ISSN
1474-175X
1474-1768